Debra Liebert

Debra Liebert

Director/Board Member at MILESTONE PHARMACEUTICALS INC.

Net worth: 227 $ as of 30/03/2024

67 year
Health Technology
Consumer Services
Commercial Services

Profile

Debra K.
Liebert
is the founder of Calixa Therapeutics, Inc., Nanothera Corp., Sonexa Therapeutics, Inc., Merada Therapeutics, Inc. She is currently an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. Her former positions include Executive Director-New Product Management at CancerVax Corp., Managing Director at Domain Associates LLC, Vice President-Corporate Development at Trega Biosciences, Inc., and Vice President-Corporate Development at LPL Technologies, Inc. Liebert holds an MBA from the University of California, Los Angeles, an undergraduate degree from Clarion University of Pennsylvania, and a graduate degree from Duquesne University of The Holy Spirit.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/06/2023 127 ( 0.00% ) 227 $ 30/03/2024

Debra Liebert active positions

CompaniesPositionStart
MILESTONE PHARMACEUTICALS INC. Director/Board Member 31/05/2015
All active positions of Debra Liebert

Former positions of Debra Liebert

CompaniesPositionEnd
Merada Therapeutics, Inc. Founder -
Nanothera Corp. Founder -
Founder -
Founder -
Corporate Officer/Principal -
See the detail of Debra Liebert's experience

Training of Debra Liebert

University of California, Los Angeles Masters Business Admin
Clarion University of Pennsylvania Undergraduate Degree
Duquesne University of The Holy Spirit Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Debra Liebert's experience

Connections

99

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
MILESTONE PHARMACEUTICALS INC.

Health Technology

Private companies8

Health Technology

CancerVax Corp.

Commercial Services

Health Technology

Nanothera Corp.

Finance

Health Technology

Health Services

Merada Therapeutics, Inc.

See company connections